AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
216.66
+2.37 (1.11%)
At close: Mar 10, 2025, 4:02 PM
216.97
+0.31 (0.14%)
After-hours: Mar 10, 2025, 6:41 PM EST
AbbVie Operating Expense Breakdown
History
| Date | Research and Development | Selling, General, and Administrative | Acquired In-Process R&D | Other |
|---|---|---|---|---|
| Dec 31, 2024 | 12.79B | 14.75B | 2.76B | -7.00M |
| Sep 30, 2024 | 7.94B | 14.09B | 1.47B | - |
| Jun 30, 2024 | 7.54B | 13.26B | 1.45B | - |
| Mar 31, 2024 | 7.32B | 13.15B | 792.00M | - |
| Dec 31, 2023 | 7.68B | 12.87B | 778.00M | - |
| Sep 30, 2023 | 7.54B | 13.10B | 739.00M | - |
| Jun 30, 2023 | 7.43B | 13.03B | 713.00M | 49.00M |
| Mar 31, 2023 | 7.31B | 15.17B | 702.00M | 46.00M |
| Dec 31, 2022 | 6.51B | 15.26B | 697.00M | 56.00M |
| Sep 30, 2022 | 6.55B | 15.10B | 859.00M | 57.00M |
| Jun 30, 2022 | 6.59B | 14.88B | 1.22B | 328.00M |
| Mar 31, 2022 | 6.75B | 12.63B | 1.08B | - |
| Dec 31, 2021 | 6.92B | 12.35B | 1.12B | - |
| Sep 30, 2021 | 6.99B | 12.32B | 1.02B | 432.00M |
| Jun 30, 2021 | 7.03B | 12.08B | 662.00M | -68.00M |
| Mar 31, 2021 | 6.85B | 12.45B | 1.38B | - |
| Dec 31, 2020 | 6.56B | 11.30B | 1.20B | - |
| Sep 30, 2020 | 6.21B | 10.02B | 1.04B | - |
| Jun 30, 2020 | 6.79B | 8.83B | 992.00M | - |
| Mar 31, 2020 | 6.50B | 6.96B | - | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.